US Broker Ratings

Dyne Therapeutics, Inc. (DYN) Stock Analysis: 178.4% Potential Upside Sparks Investor Interest

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its ambitious approach to tackling neuromuscular diseases. This clinical-stage company, headquartered in Waltham, Massachusetts, is harnessing its..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, offers a compelling investment opportunity with a potential upside..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 55% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is capturing investor attention with a robust potential upside of approximately 55.28%. Specializing in medical care facilities, Astrana Health..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Buy Ratings and 14.22% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has emerged as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market cap of $2.05..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 76% Potential Upside in the Biotechnology Sector

Investors with an eye on the healthcare sector might want to pay close attention to MiMedx Group, Inc. (NASDAQ: MDXG), a company entrenched in the biotechnology industry. With its focus..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unpacking a 9.16% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a notable player in the medical care facilities industry, offers a compelling investment narrative with a promising 9.16% potential upside. With a market capitalization..

The Pennant Group, Inc. (PNTG) Investor Outlook: Exploring a 33% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a key player in the U.S. healthcare sector, commands attention with its focus on home health, hospice services, and senior living. Operating across several..

Novavax, Inc. (NVAX) Investor Outlook: Exploring a 45.86% Upside Potential

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, has been a focal point of attention for investors, particularly following the development and commercialization of its COVID-19 vaccine, NVX-CoV2373...

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 51% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling opportunity for investors looking to capitalize on potential growth in..

Immunovant, Inc. (IMVT): Investor Outlook on a Potential 148% Upside in Biotech

Immunovant, Inc. (IMVT) stands as a notable player in the biotechnology sector, specifically focusing on the development of monoclonal antibodies to tackle autoimmune diseases. Based in New York and founded..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unveiling a Potential 189% Upside in the Biotechnology Sector

Structure Therapeutics Inc. (NASDAQ: GPCR) is making waves in the biotechnology sector with its promising pipeline of therapeutics aimed at addressing chronic diseases with significant unmet medical needs. Headquartered in..

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Healthcare Frontier with an 11.28% Potential Upside

Teladoc Health, Inc. (TDOC), a key player in the ever-evolving healthcare industry, has captured the attention of investors with its robust virtual healthcare services and a notable potential upside of..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: 29.83% Upside Potential with Innovative Spinal Solutions

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, specifically within the medical devices industry, has been capturing the attention of investors with its remarkable growth trajectory..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a 115% Potential Upside for Savvy Investors

Innoviva, Inc. (INVA), a biotechnology company based in Burlingame, California, is making waves in the healthcare sector with its promising stock potential. With a market cap of $1.2 billion and..

10x Genomics, Inc. (TXG) Stock Analysis: Exploring a 32.91% Potential Upside in the Healthcare Sector

10x Genomics, Inc. (NASDAQ: TXG) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Pleasanton, California, this life science technology company has..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 146.60% Upside Amidst Market Challenges

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, offers a diverse portfolio in diagnostics and pharmaceuticals that caters to both domestic and international markets. Despite experiencing..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Innovator with a 31% Potential Upside

Tarsus Pharmaceuticals, Inc. (TARS) is capturing the attention of investors with its compelling growth narrative and significant market potential in the healthcare sector. As a commercial-stage biopharmaceutical company, Tarsus focuses..

Liquidia Corporation (LQDA) Stock Analysis: Biotechnology Innovator Shows 60.82% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a prominent player in the biotechnology industry, stands out with a robust 60.82% potential upside according to analyst ratings. As the company continues to innovate in..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Promising 117% Upside in the Biotechnology Sector

Vera Therapeutics, Inc. (NASDAQ: VERA) is positioning itself as a potentially high-reward player in the biotechnology sector, with its focus on developing transformative treatments for serious immunological diseases. With a..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 5.87% Potential Upside in the Dental Industry

Envista Holdings Corporation (NYSE: NVST) is a notable player within the healthcare sector, specifically focusing on the medical instruments and supplies industry. With a market capitalization of $3.38 billion, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds